These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16734973)

  • 21. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
    Nordly P; Madsen HB; Nielsen HM; Foged C
    Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric particles in vaccine delivery.
    Rice-Ficht AC; Arenas-Gamboa AM; Kahl-McDonagh MM; Ficht TA
    Curr Opin Microbiol; 2010 Feb; 13(1):106-12. PubMed ID: 20079678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microparticles as vaccine adjuvants and delivery systems.
    O'Hagan DT; Singh M
    Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants.
    Madrigal-Carballo S; Vila AO; Sibaja M; Reed JD; Molina F
    J Liposome Res; 2010 Mar; 20(1):1-8. PubMed ID: 19514859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in particulate-based vaccines.
    Perrie Y; Kirby D; Bramwell VW; Mohammed AR
    Recent Pat Drug Deliv Formul; 2007; 1(2):117-29. PubMed ID: 19075879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
    Friede M; Aguado MT
    Adv Drug Deliv Rev; 2005 Jan; 57(3):325-31. PubMed ID: 15560944
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.
    Malyala P; O'Hagan DT; Singh M
    Adv Drug Deliv Rev; 2009 Mar; 61(3):218-25. PubMed ID: 19168103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells.
    Thiele L; Merkle HP; Walter E
    Expert Rev Vaccines; 2002 Aug; 1(2):215-26. PubMed ID: 12901560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and delivery of non-parenteral vaccines.
    Nugent J; Po AL; Scott EM
    J Clin Pharm Ther; 1998 Aug; 23(4):257-85. PubMed ID: 9867311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of the activity of mucosal vaccines by immunological adjuvants.
    Dima VF; Balotescu C; Dima SV
    Roum Arch Microbiol Immunol; 2000; 59(3):157-210. PubMed ID: 11850877
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.
    Kirby DJ; Rosenkrands I; Agger EM; Andersen P; Coombes AG; Perrie Y
    J Drug Target; 2008 Aug; 16(7):543-54. PubMed ID: 18686124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in immunological adjuvants: the development of particulate antigen delivery systems.
    O'Hagan DT
    Expert Opin Investig Drugs; 1998 Mar; 7(3):349-59. PubMed ID: 15991977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.